Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Galactooligosaccharides (GOS) Promote the Proliferation of Bifidobacteria and May be a Viable Management Strategy for Lactose Intolerance Symptoms

NCT06915129 is registered in ClinicalTrials.gov with Oregon State University as lead sponsor.

NCT NCT06915129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06915129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Galactooligosaccharides (GOS) Promote the Proliferation of Bifidobacteria and May be a Viable Management Strategy for Lactose Intolerance Symptoms
Lead sponsor
Oregon State University
Phase
Not applicable
Overall status
Completed
Start date
October 25, 2021
Completion date
December 6, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

modulation of the human gut microbiota by prebiotic galactooligosaccharides (gos)